Alyeska Investment Group Portfolio holdings
AUM
$28.2B
1-Year Return
38.86%
This Quarter Return
+9.63%
1 Year Return
+38.86%
3 Year Return
+101.95%
5 Year Return
+160.93%
10 Year Return
+424.53%
AUM
$16.1B
AUM Growth
+$1.17B
(+7.9%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
13.92%
Holding
646
New
153
Increased
115
Reduced
140
Closed
146
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$269M |
| 2 |
Broadcom
AVGO
|
$192M |
| 3 |
AstraZeneca
AZN
|
$150M |
| 4 |
Intuitive Surgical
ISRG
|
$150M |
| 5 |
TE Connectivity
TEL
|
$146M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$480M |
| 2 |
AerCap
AER
|
$204M |
| 3 |
Western Digital
WDC
|
$184M |
| 4 |
Akamai
AKAM
|
$127M |
| 5 |
Illumina
ILMN
|
$112M |
Sector Composition
| 1 | Technology | 22.16% |
| 2 | Consumer Discretionary | 14.37% |
| 3 | Industrials | 13.47% |
| 4 | Healthcare | 12.99% |
| 5 | Financials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUNA
351
Auna
AUNA
$471M
| $2.66M | 0.02% |
+250,000
| New | +$2.66M |
|
|
ELME
352
Elme Communities
ELME
$1.52B
| $2.65M | 0.02% |
+190,331
| New | +$2.65M |
|
353
Ichor Holdings
ICHR
$579M
| $2.51M | 0.02% |
+65,000
| New | +$2.51M |
|
354
Reddit
RDDT
$44.9B
| $2.47M | 0.02% |
+50,000
| New | +$2.47M |
|
355
STAAR Surgical
STAA
$1.38B
| $2.46M | 0.02% |
+64,185
| New | +$2.46M |
|
356
Monolithic Power Systems
MPWR
$41.5B
| $2.31M | 0.01% |
3,410
-29,610
| -90% | -$20.1M |
|
357
Five Star Bancorp
FSBC
$702M
| $2.25M | 0.01% |
+100,000
| New | +$2.25M |
|
|
CYBN
358
Cybin
CYBN
$159M
| $2.23M | 0.01% |
142,233
-7,325
| -5% | -$115K |
|
359
Achieve Life Sciences
ACHV
$145M
| $2.14M | 0.01% |
+471,000
| New | +$2.14M |
|
360
Aquestive Therapeutics
AQST
$656M
| $2.13M | 0.01% |
+500,000
| New | +$2.13M |
|
361
Treace Medical Concepts
TMCI
$453M
| $2.05M | 0.01% |
156,795
-25,317
| -14% | -$330K |
|
362
MeiraGTx Holdings
MGTX
$619M
| $2M | 0.01% |
330,182
| – | – |
|
363
Absci
ABSI
$368M
| $1.99M | 0.01% |
+350,000
| New | +$1.99M |
|
364
Novartis
NVS
$251B
| $1.97M | 0.01% |
20,321
-735,078
| -97% | -$71.1M |
|
365
Popular Inc
BPOP
$8.47B
| $1.91M | 0.01% |
+21,697
| New | +$1.91M |
|
366
Fulcrum Therapeutics
FULC
$414M
| $1.91M | 0.01% |
202,148
| – | – |
|
367
GCM Grosvenor
GCMG
$680M
| $1.85M | 0.01% |
191,053
| – | – |
|
368
Viridian Therapeutics
VRDN
$1.53B
| $1.75M | 0.01% |
+100,000
| New | +$1.75M |
|
369
DoubleVerify
DV
$2.45B
| $1.75M | 0.01% |
49,779
-827,537
| -94% | -$29.1M |
|
|
370
Western Digital
WDC
$31.9B
| $1.74M | 0.01% |
33,781
-3,575,190
| -99% | -$184M |
|
371
Tourmaline Bio
TRML
$687M
| $1.72M | 0.01% |
+75,000
| New | +$1.72M |
|
372
Xerox
XRX
$493M
| $1.69M | 0.01% |
94,522
-126,125
| -57% | -$2.26M |
|
373
Allegro MicroSystems
ALGM
$5.66B
| $1.62M | 0.01% |
+60,000
| New | +$1.62M |
|
374
Kyverna Therapeutics
KYTX
$170M
| $1.61M | 0.01% |
+65,000
| New | +$1.61M |
|
|
BLUE
375
DELISTED
bluebird bio
BLUE
| $1.61M | 0.01% |
62,797
-282,828
| -82% | -$7.24M |
|